These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9064357)

  • 41. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
    J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Letter: Epstein-Barr virus and infectious mononucleosis.
    Royston I
    Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
    [No Abstract]   [Full Text] [Related]  

  • 45. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus in a CD8-positive T-cell lymphoma.
    Richel DJ; Lepoutre JM; Kapsenberg JG; Ooms EC; Boom WR; Boucher CA; Kluin PM
    Am J Pathol; 1990 May; 136(5):1093-9. PubMed ID: 2161617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2.
    Longnecker R
    Leukemia; 1994 Apr; 8 Suppl 1():S46-50. PubMed ID: 8152303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
    Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P; Ernberg I; Klein G; Steinitz M
    Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic and cellular changes associated with loss of antigen-induced function in Epstein-Barr virus-specific human T-cell hybrids.
    Gallagher G
    Int Arch Allergy Appl Immunol; 1989; 88(3):353-6. PubMed ID: 2542166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells.
    Rickinson AB; Wallace LE; Epstein MA
    Nature; 1980 Feb; 283(5750):865-7. PubMed ID: 6244495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus increases the proliferative response and the generation of suppressor and cytotoxic T-cell functions in autologous mixed lymphocyte reaction.
    Palacios R
    Scand J Immunol; 1982 Jan; 15(1):17-24. PubMed ID: 6280268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infectious mononucleosis: model for self-limiting lymphoproliferation.
    Carter RL
    Lancet; 1975 Apr; 1(7911):846-9. PubMed ID: 48066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.